Latest Articlesddd
Inovio Pharmaceuticals Promising Results for INO-4800 for COVID-19 Inovio Pharmaceuticals (INO) announces promising results of a …
FDA Grants Accelerated Approval for Gilead Sciences Trodelvy® The United States Food and Drug Administration (FDA) …
vTv Therapeutics Receives Breakthrough Therapy Designation for TTP399 vTv Therapeutics (VTVT) - a clinical-stage biopharmaceutical company …
Prohost Portfolio PLUS #2 Re-Working Some Evaluated Biotechnology Firms Exelixis: 2020 and 2021 Wondering why Exelixis’ …
Gilead Sciences is Granted FDA Approval for Trodelvy® Gilead Sciences (GILD), a company that has been …
Exelixis Latest News The latest news announced by Exelixis (EXEL) is the FDA acceptance of its …
Intellia Therapeutics NTLA-2001 for ATTR Granted Orphan Drug Designation by the EC Intellia Therapeutics (NTLA) announced …
Exelixis Boxed in on Good News Exelixis (EXEL) is one of the firms boxed in by …
Illumina Acquisition of GRAIL On September 21, 2020, Illumina and GRAIL Inc. announced that they entered into …
Rubius Therapeutics Finding small development-stage biotech firms that contribute to biotechnology's limitless revolution of the biological …
Prohost Portfolio PLUS (formerly The Week in Review) Your Questions, Our Answers In the upcoming issues …
Current Presentations from Intellia Therapeutics Intellia Therapeutics (NTLA) is presenting the first preclinical data set on …
Novartis Positive Results for Radioligand Therapy, 177Lu-PSMA-617, for mCRPC Novartis (NVS) reported the first interpretable results …
Prohost Letter #445 A Flashback and Future Projections 1. A Follow-Up on Recently Posted News from …
Negative News from Ionis Pharmaceuticals Ionis Pharmaceuticals (IONS) announced that its partner, Roche (RHHBY),
CureVac CureVac B.V. (CVAC) is a global biopharmaceutical company specializing in messenger RNA (mRNA) technology. The …
AstraZeneca to Supply Additional Doses of AZD7442 to the U.S. for COVID-19 AstraZeneca (AZN) has modified …
Immutep Ltd and Merck Announce Second Clinical Trial Collaboration Immutep (IMMP) develops novel immunotherapy treatments for …
Gilead Sciences and Merck Announced Agreement for Long-Term HIV Combination Treatment Gilead Sciences (GILD) and Merck …
Anixa Biosciences Outperformance Anixa Biosciences Inc (ANIX) is the worldwide licensee of a patent technology titled …
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Accept Privacy policy
